Abstract

Two representatives of the low (human Enzyme B and horse Enzyme B) and two representatives of the high (bovine Enzyme B and human Enzyme C) catalytic activity forms of erythrocyte carbonic anhydrase were reacted with bromoacetate and bromoacetazolamide with the aim of elucidating structural differences at their active sites. The dissociation constants of the reversible inhibition of bromoacetate and bromoacetazolamide have been determined. It was found that the constants for bromoacetate showed 25- to 30-fold differences between the low and high activity forms of the enzyme, but only 1.1- to 6-fold differences within one activity type. The dissociation constants of the enzyme-bromoacetazolamide complex were almost the same for the two groups. Several lines of evidence suggest that bromoacetazolamide inactivates both types of enzymes with simultaneous alkylation of a histidine (or histidines) at or near the active site at the 3-nitrogen position. The rate of alkylation is, however, markedly different for the two types. Stoichiometric amounts of this inhibitor partially alkylate a histidine of the high catalytic activity forms, but do not react with the low catalytic activity forms. At higher inhibitor concentrations both types react, but the high activity forms react significantly faster. By contrast, bromoacetate at low concentrations inactivates exclusively the low catalytic activity forms with the carboxymethylation of a histidine at the 3-nitrogen position. Evidence is presented that this reaction for the horse enzyme occurs at or near the active site. At higher inhibitor concentrations the high catalytic activity forms also became inactivated, but this reaction is nonspecific. The half-times of the inactivation by bromoacetate were also determined. These values for the high catalytic activity enzymes were found to be 36 times greater than could be explained on a basis of enzyme-inhibitor complex concentration. It is suggested that a difference in the conformation of the active site, or a steric hindrance brought about by an amino acid side chain sufficiently close to the reactive histidine, would account for the observed differences in the rates of alkylation and inactivation.

Highlights

  • The dissociation constants of the reversible inhibition of bromoacetate and bromoacetazolamide have been determined

  • Enzyme B and human Enzyme C) catalytic activity forms of erythrocyte carbonic anhydrase were reacted with bromoacetate and bromoacetazolamide with the aim of elucidating structural differences at their active sites

  • It was found that the constants for bromoacetate showed 25- to 30-fold differences between the low and high activity forms of the enzyme, but only l.l- to 6-fold differences within one activity type

Read more

Summary

SUMMARY

Two representatives of the low (human Enzyme B and horse Enzyme B) and two representatives of the high It has been shown that the innctivation is preceded by the formation of an enzyme-inhibitor complex, indicating that the inactivation occurs via the active site (l-3) These investigations have revealed that bromoacetate at a concentration that almost’ completely inactivated human B does not inactivate human C (2) or bovine B carbonic anhydrases (3). The latter two enzymes differ from the previous one in that they catalyze several times faster the reversible hydration of COZ as well as the hydrolysis of esters (4) It is the purpose of the present paper to describe further investigations of the covalent interaction of bromoacetate and bromoacetazolamide with human, bovine, and horse carbonic anhydrases and to consider the implications of the resulting dat,a on the relationship between the chemical reactivity of the active site histidine and the catalytic activity of carbonic anhydrase isoenzymes

MATERIALS AND METIIODS
RESULTS
Inhibitor concenttstion tion of enzymeinhibitor complex
Irreversible inhibition
TABLE V
Modified amino acid formed
Some Characteristics oj Carbonic Anhydrase Isoenzymes
Native enzyme plus bromoacetazolamide
DISCUSSION
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call